 Connection
Eliza Blanchette to Immunosuppressive Agents
This is a "connection" page, showing publications Eliza Blanchette has written about Immunosuppressive Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.206 |
|
|
|
-
Chandran MM, Blanchette E, Goebel J, Bock M. Impact of once-daily ER-Tac on trough concentration variability in a stable AYA renal transplant recipient cohort. Pediatr Transplant. 2021 Sep; 25(6):e14036.
Score: 0.127
-
Dharnidharka VR, Scobell RR, Kallash M, Davies AJG, Marchesani N, Maltenfort MG, Walther L, Kelton M, Bock M, Blanchette E, Stone HK, Gluck C, Hullekes F, Riella LV, Smoyer WE, Mitsnefes M, Dixon BP, Flynn JT, Somers MJG, Forrest CB, Furth S, Denburg MR. Clinical characteristics and favorable treatment responses of recurrent focal segmental glomerulosclerosis or?steroid-resistant nephrotic syndrome in children after kidney transplantation. Pediatr Nephrol. 2024 Nov; 39(11):3317-3331.
Score: 0.040
-
Aldieri A, Chandran M, Matossian D, Hariprasad A, Magella B, Lazear D, Blanchette E, Benz E, Bock M. Leflunomide as adjunct therapy for BK viremia management in pediatric kidney transplant recipients. Pediatr Transplant. 2024 Mar; 28(2):e14724.
Score: 0.039
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|